Physician profile
Sarah Smith
NPI 1194108936
$3,037.11
in general payments reported to CMS, 2019-2025
17 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $535 · 2022: $745 · 2023: $607 · 2024: $833 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,757.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $587.08 | 2021-2025 | Farxiga, Breztri |
| Abbott Laboratories | $459.41 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Freestyle Libre 3 |
| Novo Nordisk INC | $366.22 | 2021-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $330.49 | 2021-2022 | |
| Amgen INC. | $145.61 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $116.43 | 2024 | Exparel |
| Idorsia Pharmaceuticals US INC | $114.91 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $113.68 | 2022 | |
| Stryker Corporation | $108.68 | 2024 | Scopis Ent |
| E.R. Squibb & Sons, L.L.C. | $107.91 | 2022 | |
| Alcresta Therapeutics, INC. | $107.66 | 2023 | Relizorb |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2021 | |
| Abbvie INC. | $99.76 | 2022 | |
| Viiv Healthcare Company | $92.96 | 2025 | |
| Veloxis Pharmaceuticals, INC. | $80.02 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zambon USA LTD. | $73.97 | 2024 | |
| Alexion Pharmaceuticals, INC. | $32.32 | 2025 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.